Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection

by Christine Katlama, Robert Murphy
Published 2009-04-01

Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.

by Matthieu Lafaurie, Barbara De Sousa, Diane Ponscarme, Nathanael Lapidus, Michel Daudon, Laurence Weiss, Christophe Rioux, Erwan Fourn, Christine Katlama, Jean-Michel Molina
Published 2014-01-01

Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis

by Ruxandra Calin, Eric Caumes, Florence Reibel, Anzime Ali Mohamed, Florence Brossier, Violaine Foltz, Samia Boussouar, Bruno Fautrel, Max Maurin, Christine Katlama, Valérie Pourcher
Published 2017-07-01

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study.

by Johannes S Gach, Chad J Achenbach, Veronika Chromikova, Baiba Berzins, Nina Lambert, Gary Landucci, Donald N Forthal, Christine Katlama, Barbara H Jung, Robert L Murphy
Published 2014-01-01

Impact of lean mass and bone density on glomerular filtration rate estimation in people living with HIV/AIDS.

by Corinne Isnard Bagnis, Laurence Pieroni, Rachida Inaoui, Philippe Maksud, Stéphanie Lallauret, Marc-Antoine Valantin, Roland Tubiana, Christine Katlama, Gilbert Deray, Marie Courbebaisse, Jérôme Tourret, Sophie Tezenas du Montcel
Published 2017-01-01

Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

by Behazine Combadière, Annika Vogt, Brice Mahé, Dominique Costagliola, Sabrina Hadam, Olivia Bonduelle, Wolfram Sterry, Shlomo Staszewski, Hans Schaefer, Sylvie van der Werf, Christine Katlama, Brigitte Autran, Ulrike Blume-Peytavi
Published 2010-05-01

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.

by Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, Cathia Soulie, Slim Fourati, Marc Wirden, Sophie Sayon, Sophie Pakianather, Laurence Bocket, Bernard Masquelier, Georges Dos Santos, Christine Katlama, Vincent Calvez, Anne-Genevieve Marcelin
Published 2012-01-01

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).

by Charlotte Charpentier, Catherine Fagard, Céline Colin, Christine Katlama, Jean-Michel Molina, Christine Jacomet, Benoit Visseaux, Anne-Marie Taburet, Françoise Brun-Vézinet, Geneviève Chêne, Yazdan Yazdanpanah, Diane Descamps, ANRS139 TRIO Trial study group
Published 2013-01-01

A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review.

by Joseph Cox, Cassidy Gutner, Nadine Kronfli, Anna Lawson, Michele Robbins, Lisette Nientker, Amrita Ostawal, Tristan Barber, Davide Croce, David Hardy, Heiko Jessen, Christine Katlama, Josep Mallolas, Giuliano Rizzardini, Keith Alcorn, Michael Wohlfeiler, Eric Le Fevre
Published 2019-01-01

CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.

by Sylvain Cardinaud, Gesa Consiglieri, Romain Bouziat, Alejandra Urrutia, Stéphanie Graff-Dubois, Slim Fourati, Isabelle Malet, Julien Guergnon, Amélie Guihot, Christine Katlama, Brigitte Autran, Peter van Endert, François A Lemonnier, Victor Appay, Olivier Schwartz, Peter M Kloetzel, Arnaud Moris
Published 2011-05-01

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

by Frank van Leth, Prahpan Phanuphak, Erik Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J P Kastelein, Mauro Schechter, Robert L Murphy, Andrzej Horban, David B Hall, Joep M A Lange, Peter Reiss
Published 2004-10-01

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the N...

by Jose I Bernardino, Amanda Mocroft, Cedrick Wallet, Stéphane de Wit, Christine Katlama, Peter Reiss, Patrick W Mallon, Laura Richert, Jean-Michel Molina, Hernando Knobel, Philippe Morlat, Abdel Babiker, Anton Pozniac, Francois Raffi, Jose R Arribas, NEAT001/ANRS143 Trial Study Group
Published 2019-01-01

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.

by Johannes S Gach, Andrea Gorlani, Emmanuel Y Dotsey, Juan C Becerra, Chase T M Anderson, Baiba Berzins, Philip L Felgner, Donald N Forthal, Steven G Deeks, Timothy J Wilkin, Joseph P Casazza, Richard A Koup, Christine Katlama, Brigitte Autran, Robert L Murphy, Chad J Achenbach
Published 2016-01-01

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

by Clotilde Allavena, Matthieu Hanf, David Rey, Claudine Duvivier, Firouze BaniSadr, Isabelle Poizot-Martin, Christine Jacomet, Pascal Pugliese, Pierre Delobel, Christine Katlama, Véronique Joly, Christian Chidiac, Nathalie Dournon, Dominique Merrien, Thierry May, Jacques Reynes, Amandine Gagneux-Brunon, Catherine Chirouze, Thomas Huleux, André Cabié, François Raffi, Dat’AIDS study group
Published 2018-01-01

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.

by Charline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, Georges Nembot, Adeline Mélard, Catherine Blanc, Caroline Lascoux-Combe, Laurence Slama, Thierry Allegre, Clotilde Allavena, Yazdan Yazdanpanah, Claudine Duvivier, Christine Katlama, Cécile Goujard, Bao Chau Phung Seksik, Anne Leplatois, Jean-Michel Molina, Laurence Meyer, Brigitte Autran, Christine Rouzioux, OPTIPRIM ANRS 147 study group
Published 2013-01-01

Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study.

by Enrique Casalino, Bruno Bernot, Olivier Bouchaud, Chakib Alloui, Christophe Choquet, Elisabeth Bouvet, Florence Damond, Sandra Firmin, Aurore Delobelle, Beatrice Ename Nkoumazok, Guillaume Der Sahakian, Jean-Paul Viard, Olivier Zak Dit Zbar, Elisabeth Aslangul, Anne Krivine, Julie Zundel, Jade Ghosn, Patrice Nordmann, Yann-Erick Claessens, Tassadit Tahi, Bruno Riou, Agnès Gautheret-Dejean, Christine Katlama, Pierre Hausfater, Françoise Brun-Vézinet, Dominique Costagliola
Published 2012-01-01

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.

by Oumar Billa, Mathieu Chalouni, Dominique Salmon, Isabelle Poizot-Martin, Camille Gilbert, Christine Katlama, Didier Neau, Julie Chas, Philippe Morlat, Karine Lacombe, Alissa Naqvi, Karl Barange, Anne Gervais, Olivier Bouchaud, Eric Rosenthal, Caroline Lascoux-Combe, Daniel Garipuy, Laurent Alric, Stéphanie Dominguez, Daniel Vittecoq, Cécile Goujard, Claudine Duvivier, Hugues Aumaitre, Patrick Miailhes, David Zucman, Anne Simon, Estibaliz Lazaro, François Raffi, Laure Esterle, Linda Wittkop, Firouzé Bani-Sadr, ANRS CO13 HEPAVIH Study Group
Published 2018-01-01